Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Surgeons need to understand natural hair patterns for better hair restoration results.

Androgens can both increase body hair and cause scalp hair loss.

Androgens can cause hair growth in some areas but hair loss on the scalp.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

The study suggests that analyzing DNA can help treat hair loss, but more research is needed.

Androgenetic alopecia in women needs more research and better management strategies.

Some women with common hair loss may develop permanent hair loss.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

Hair care practices like using relaxers and tight braiding can lead to permanent hair loss in black women.

Optimal transplant density for Chinese male hair loss patients is 35-50 hair/cm², with minimum 106.88 hair/cm² left in donor area for esthetic satisfaction.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Hair shedding after childbirth can reveal a pre-existing condition of hair loss due to tight hairstyles.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Women with thinning hair have thinner hair strands than women without hair loss.

Hair loss in women may have causes other than hormones.

Laser treatment increases hair density and thickness safely in women with hair loss.